Document is current
Any future updates will be listed below
-
Authors
Inose, Hiroyuki https://orcid.org/0000-0003-4195-2545
Tanaka, Shiro
Mori, Satoshi
Hagino, Hiroshi
Soen, Satoshi
-
Funding
Funding for this research was provided by:
the Public Health Research Foundation
Asahi Kasei Pharma Corporation
- License Information
-
More Information
Article History
Received: 15 August 2025
Accepted: 2 December 2025
First Online: 14 December 2025
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: H Inose received speaking fees from Astellas Pharma Inc., Amgen Inc., Asahi Kasei Pharma Corp., Teijin Pharma Ltd., and Daiichi Sankyo Co.S Tanaka has received lecture fees from the Research Institute of Healthcare Data Science. He has received consultation fees and outsourcing fees from Eli Lilly and Company, Welby, Daiichi Sankyo Co., Ltd., Janssen Pharmaceutical K.K., Satt, and the Public Health Research Foundation. He has received research grants from the Japan Agency for Medical Research and Development, the Japanese Ministry of Health, Labour and Welfare, the Japanese Ministry of Education, Science and Technology, and Novo Nordisk. He engaged in a research project of the Japan Agency for Medical Research and Development.S Mori has received speaking fees from Amgen Inc., Asahi Kasei Pharma Corp., and Astellas Pharma Inc.H Hagino has received speaking fees from Amgen Inc., Asahi Kasei Pharma Corp., Astellas Pharma Inc., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., Kyowa Kirin Co., Ltd., Teijin Pharma Ltd., and UCB Japan Co., Ltd.S Soen has received consulting fees, speaking fees, and/or honoraria from Amgen Inc., Asahi Kasei Pharma Corp., Astellas Pharma Inc., Daiichi Sankyo Co., Ltd., Eli Lilly Japan Co., Ltd., Teijin Pharma Ltd., and UCB Japan Co., Ltd.
